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to produce the normative inversion. We demonstrate for 
five genomic regions, 4p16.3, 7q11.23, 11p15, 16p13.3 and 
17p11.2, that such inversion for individuals with a dupli-
cation or (epi)-mutation produces facial forms remarkably 
similar to those associated with a deletion or opposite (epi-)
mutation of the same region, and vice versa. the ability to 
visualise and quantify face shape effects of gene dosage 
is of major benefit for determining whether a Cnv is the 
cause of the phenotype of an individual and for predicting 
reciprocal consequences. It enables face shape to be used 
as a relatively simple and inexpensive functional analysis 
of the gene(s) involved.
Abstract sequencing technology is increasingly dem-
onstrating the impact of genomic copy number variation 
(Cnv) on phenotypes. Opposing variation in growth, head 
size, cognition and behaviour is known to result from dele-
tions and reciprocal duplications of some genomic regions. 
We propose normative inversion of face shape, opposing 
difference from a matched norm, as a basis for investigating 
the effects of gene dosage on craniofacial development. We 
use dense surface modelling techniques to match any face 
(or part of a face) to a facial norm of unaffected individuals 
of matched age, sex and ethnicity and then we reverse the 
individual’s face shape differences from the matched norm 
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Introduction
In recent years, genome-wide screening technologies 
have helped identify large numbers of genomic struc-
tural variants (Gsvs). Duplications and deletions, usu-
ally indicated as copy number variants (Cnvs), are the 
most prevalent Gsvs and have been shown to make 
an important contribution to development and disease 
(valsesia et al. 2013; Weischenfeldt et al. 2013). Cnvs 
have been associated with mirrored or opposing pheno-
types at several loci. For example, Cnvs of the 7q11.23 
Williams-Beuren syndrome (OMIM: #194050) region 
cause neuro developmental disorders with a multi-
faceted phenotype and variable expressivity. typically, 
individuals with 7q11.23 micro deletions have spe-
cific facial dysmorphism, supravalvular aortic steno-
sis, hypercalcaemia and a distinctive cognitive profile 
including heightened sociability and relative strength of 
language over visuo-spatial processing. In contrast, the 
7q11.23 reciprocal duplication results in different facial 
dysmorphism, low sociability and prominent speech 
delay (schubert 2009; Merla et al. 2010). this deletion-
duplication opposing nature of a phenotype also occurs 
for 17p11.2. Individuals with smith-Magenis syndrome 
(OMIM: #182290), caused by a deletion in 17p11.2 or 
point mutation in RAI at 17p11.2, exhibit attention-seek-
ing and overt friendliness (Potocki et al. 2000, 2007; 
lupski and stankiewicz 2005). In contrast, the recipro-
cal duplication causes Potocki-lupski syndrome where 
behaviour is characterized by autism spectrum disorders. 
Opposing over/undergrowth effects result from deletions 
(sotos syndrome (OMIM: #117550)) and duplications 
of NSD1 at 5q35 (Zhang et al. 2011; rosenfeld et al. 
2013; Žilina et al. 2013; Franco et al. 2010; Dikow et al. 
2013). Opposing extreme BMI phenotypes have also 
been associated with gene dosage at 16p11.2 (Jacque-
mont et al. 2011). In the two latter regions, there is also 
opposing microcephaly and macrocephaly. Hypomethyl-
ation of imprinting control region 1 at 11p15 and mater-
nal duplication of 11p15 have been described as major 
Fig. 1  normative inversion of face shape. a the face surface of an 
adult Caucasian male control. b the average face of 50 adult male 
Caucasians whose mean age matches that of a. c a heat map of the 
face signature of a normalised against the 50 individuals whose aver-
age is b. d the inverted heat map of c. e. the face surface whose face 
signature has heat map d. f Left to right a triptych of face signature, 
portrait and profile of individual 1 with a duplication of 7q11.23; 
then the normative inversion of the duplication case; and finally an 
individual with a confirmed deletion of 7q11.23 whose face closely 
resembles the inversion. g Left to right a triptych of face signature, 
portrait and profile of individual 2 with a duplication of 7q11.23; 
then the normative inversion of the duplication case; and finally an 
individual with a confirmed deletion of 7q11.23 whose face closely 
resembles the inversion. h Left to right a triptych of face signature, 
portrait and profile of individual 3 with a duplication of 7q11.23; 
then the normative inversion of the duplication case. i Left to right 
a triptych of face signature, portrait and profile of individual 4 with 
a duplication of 7q11.23; then the normative inversion of the dupli-
cation case; and finally an individual with a confirmed deletion of 
7q11.23 whose face closely resembles the inversion. note that in the 
original and inverted face signatures of rows f–h, the red–green–blue 
of the heat maps are opposite with red and blue regions interchanged. 
the red–green–blue spectrum in all images represents regions of 
contraction-coincidence-expansion relative orthogonal to the face sur-
face of the matched norm with extreme red-blue indicating difference 
beyond 2sD (color figure online)
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(epi) genetic disturbances in silver-russell syndrome 
(OMIM: # 180860) resulting in severe undergrowth. 
Opposite (epi)-mutations involved in Beckwith-Wiede-
mann syndrome (OMIM: # 130650) cause overgrowth, 
suggesting that silver-russell and Beckwith-Wiedemann 
syndromes are genetically and clinically opposite (egg-
ermann 2009).
Based on these observations, we hypothesised that 
in opposite Cnv pairings, there could be quantitatively 
opposite facial phenotypes. Facial morphology is deter-
mined in part by a large number of genes and enhancers 
acting in concert, and a decrease in dosage in some genes 
will lead to abnormal morphology at various parts of the 
face. an increase in dosage may therefore lead to a related 
abnormal morphology at the same parts of the face. to test 
this hypothesis, we developed a transformation, normative 
inversion, for reversing the differences of an individual’s 
3D face shape from a facial norm, the average of an age-
sex-ethnicity matched control group.
Methods
study participants
3D facial images were available for 387 Caucasian con-
trols and individuals with Williams-Beuren syndrome, 
smith-Magenis syndrome and Wolf-Hirschhorn syndrome 
(OMIM: # 194190) from previous studies (Hammond et al., 
2004, 2005, 2012). Individuals with rubinstein-taybi syn-
drome were recruited during attendance at national family 
support group meetings in the netherlands, norway and 
UK. through clinical co-authors, we also recruited indi-
viduals specifically for this study with confirmed mutations 
causing Beckwith-Wiedemann (n = 1) and silver-russell 
syndromes (n = 17) as well as individuals with associated 
duplications at 4p16.3 (n = 1), 7q11.23 (n = 4), 16p13.3 
(n = 1) and 17p11.2 (n = 1). all subjects were of Cauca-
sian origin except for one duplication 7q11.23 case which 
was of north african (Moroccan) origin.
Fig. 2  normative inversion of duplications of 4p16.3, 16p13.3, 
17p11.2 and H19 hypermethylation Beckwith-Wiedemann cases. 
Using the same format as Fig. 1, each row includes a face triptych 
comprising signature, portrait and profile of a duplication (4p16.3, 
16p13.3, 17p11.2) or hypermethylation (Beckwith-Wiedemann syn-
drome) case; the normative inversion of the original; and, finally 
a triptych for an individual with a deletion or mutation (Wolf–
Hirschhorn syndrome, rubinstein–taybi syndrome, smith–Magenis 
syndrome) or opposite methylation (silver–russell syndrome) whose 
face shape closely resembles that of the original case. the inversions 
of the dup 4p16.3 and Beckwith–Wiedemann cases display strong 
similarity respectively with features of Wolf–Hirschhorn and silver–
russell syndromes. the inversion of the dup 16p13.3 case displays 
rubinstein–taybi features such as hooded eyes, significant convexity 
of the zygomatic arch and exposure of the columella. although some-
what narrower than is usual in smith–Magenis syndrome, the inver-
sion of the Potocki–lupski case displays the typical upward curve to 
the upward lip, the hidden columella and mid-facial flatness
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normative inversion of facial morphology
Initially, we constructed a dense surface model (DsM) of 
the 3D facial images of individuals with an identified syn-
drome or Cnv and the 387 controls (Hammond and suttie 
2012). In such models, we retain sufficient principle com-
ponent analysis (PCa) modes to cover 99 % of all shape 
variation. the inclusion of a large number of controls and 
a high proportion of PCa modes enables accurate synthesis 
of faces in the model.
the subset of controls of the same ethnicity and gen-
der were ordered by age and a series of running mean 
faces of 50 contiguously aged individuals were computed. 
this enabled every face to be matched to a same ethnic-
ity-gender facial norm of closely matched age. Within the 
multi-dimensional DsM representation, all faces were pro-
jected onto a hyperline from the face being inverted based 
at (1, 0) to the matched norm based at (−1, 0). the line 
was extended to a point the same distance away at (−3, 0) 
where the face shape corresponds to an inverted facial form 
whose shape differences from the norm are exactly oppo-
site to those of the original face. such a normative inver-
sion can be applied to any face.
a similar notion of facial inversion, termed anti-face, 
was previously used to investigate psychological aspects of 
the perception of face shape differences (Blanz et al. 2000). 
In this earlier study, various mean faces were employed to 
compute an opposite face shape, sometimes even based on 
a mixed set of male and female individuals. therefore, we 
retain the use of “normative inversion” in order to empha-
size the age-sex-ethnicity matched nature of the mean used 
in our inversion process.
the face signature of an individual is the term used 
for its 3D shape difference from its matched norm (Ham-
mond and suttie 2012). It can be visualised as a heat 
map reflecting the normalized differences at each of 
25,000 + surface points captured by commercial 3D 
imaging devices. Figure 1a, c show the face surface and 
signature heat map of one of the authors where the red–
green–blue spectrum highlights regional differences 
Fig. 3  Closest mean classifica-
tion of inversions of dup7q11.23 
cases. the arrows emphasise 
position change in closest mean 
classification for the faces of the 
duplication cases in Fig. 1f–h 
and their normative inversions. 
the horizontal axis determines 
relative similarity to the mean 
of the control group compared 
to the mean of the affected 
group. the vertical axis reflects 
the outlier status in terms of 
distance from the hyperline 
linking the means of the two 
groups under comparison. In a, 
the inversions of two duplica-
tion cases are classified at the 
periphery of the Williams–
Beuren syndrome cluster. a 
third duplication inverts to well 
within the Williams–Beuren 
syndrome cluster. In b, when 
only the curvilinear mid-line 
facial profile is considered, 
all inversions are within the 
Williams–Beuren syndrome 
cluster. this is consistent with 
clinical evaluation suggest-
ing the inverted faces to be 
somewhat wider than the typical 
Williams-Beuren syndrome 
facies but very Williams–
Beuren syndrome-like in nose, 
lips and mid-line profile
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(contraction-coincidence-expansion) orthogonal to the 
face surface compared to the matched norm. the extremes 
of red and blue reflect normalised differences of ± 2 sDs 
or more. Figure 1b shows the matched facial norm and 
Fig. 1d, e the surface and heat map of the normative inver-
sion of a with respect to B. We apply an analogous trans-
formation to all faces of interest.
Results
In Fig. 1f–i, we demonstrate the effect of inverting the 
face shape of three unpublished individuals and one previ-
ously published individual with a duplication of 7q11.23 
(Malenfant et al. 2012). Clinically, the features of the nor-
mative inversions of their faces strongly resemble those 
of Williams-Beuren syndrome (flat nasal bridge, short 
upturned nose, long philtrum, full lips, malar flattening, and 
micro/retrognathia). this similarity is further emphasised 
by their comparison with three adjacent faces of individuals 
with a confirmed 7q11.23 Williams-Beuren syndrome dele-
tion. to test normative face inversion further, the procedure 
was repeated for individuals with duplications of 4p16.3, 
16p13.3 and 17p11.1, and with Beckwith-Wiedemann syn-
drome caused by H19 hypermethylation. Clinical evaluation 
of the normative inversions of facial features of these cases 
establishes their similarity to facial characteristics of indi-
viduals with Wolf-Hirschhorn (Fig. 2a), rubinstein-taybi 
(Fig. 2b), smith–Magenis (Fig. 2c) and silver–russell syn-
dromes due to H19 hypomethylation (Fig. 2d), respectively.
a convincing objective confirmation of these clini-
cal observations would be to demonstrate the effect of 
Fig. 4  Closest mean classification of face for individuals with dupli-
cations of 4p16.3, 16p13.3 and H19 hypermethylation, and their nor-
mative inversions. scatter plots a–c depict the results of closest mean 
classification of paired groups: controls and affected individuals with 
Wolf–Hirschhorn syndrome, silver–russell syndrome or rubinstein–
taybi syndrome. the arrows indicate the change in closest mean 
classification position of an individual and their normative inversion. 
In each case, the result of the normative inversion is to alter the origi-
nal face to be more like individuals in the affected group. each scat-
ter provides quantitative corroboration of the clinical evaluation of 
the face shape change resulting from the inversion
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normative inversion along a duplication-deletion axis—for 
example, classifying each duplication case and its inverse 
relative to proximity to the mean duplication and mean 
deletion cases (taking care to omit the test individual from 
the calculation of the mean duplication). But there are an 
insufficient number of identified duplication cases available 
and so a compromise was to measure the effect of inver-
sion of the face of an individual with a duplication along 
a control-deletion axis. a moment’s reflection confirms 
that as a result of normative inversion there would be much 
stronger movement of closest mean classification along a 
duplication-deletion axis than along a control-deletion axis, 
as the duplication group mean would be more “repulsing” 
to the inverted duplication. But until more duplication 
cases can be identified, the control-deletion axial compari-
son will have to substitute for the duplication-deletion axial 
comparison.
We computed the change in relative similarity to the 
average faces of controls and individuals with Williams–
Beuren syndrome resulting from normative inversion of 
the faces of each duplication 7q11.23 case. Using the full 
face without ears, the inverted facial forms are classified at 
the periphery of, or within, the Williams-Beuren syndrome 
cluster (Fig. 3a). thus, normative inversion produces con-
siderable position change from proximity to the average 
control towards the average Williams–Beuren syndrome 
face. For a thin ribbon-like surface along the mid-line facial 
profile (see Fig. s1 in supplementary material), normative 
inversion of all three duplication 7q11.23 cases results in 
even stronger classification within the Williams-Beuren 
syndrome cluster (Fig. 3b). these quantitative results con-
firm the clinical interpretation of the inverted face signa-
tures as being Williams–Beuren syndrome-like, especially 
in the facial mid-line.
Classification of face shape using the closest mean algo-
rithm also produced positive recognition of the relevant 
facial characteristics for the other four genomic regions 
(Figs. 4, 5). For the smith–Magenis and Potocki–lupski 
syndromes comparison at 17p11.2, an additional shape 
classification for the mid-line facial profile was undertaken 
to demonstrate once again that shape inversion of a more 
localised region can produce more convincing objective 
results (Fig. 5).
the paucity of cases with duplications meant that we 
could not even carry out a compromise control-duplication 
axial comparison to provide more objective evidence of 
the effect of normative facial inversion on deletion cases. 
Instead, we applied normative inversion to individuals 
with Wolf–Hirschhorn, Williams–Beuren, silver–russell, 
rubinstein–taybi and smith–Magenis syndromes to dem-
onstrate the similarity of their inversions to individuals in 
the published literature with corresponding duplications/
mutations at 4p16.3, 7q11.23, 11p15, 16p13.3 and 17p11.2 
(supplementary Figs. s2–s6). In each of these supplemen-
tary figures, normative inversion is the only process that 
has been applied and only to the faces of the individuals 
with Wolf–Hirschhorn, Williams–Beuren, silver–russell, 
rubinstein–taybi and smith–Magenis syndromes. to dem-
onstrate the general effect of normative inversion, we also 
generated animated morphs between an average syndromic 
face and its normative inversion for each of rubinstein-
taybi, silver-russell, smith–Magenis, Williams–Beuren 
and Wolf–Hirschhorn syndromes (supplementary videos 
sv1–sv5).
In order to check the effect of normative inversion on 
unaffected controls, we used multi-folded cross validation, 
Fig. 5  Closest mean classification of face and mid-line profile for 
individual with duplication of 17p11.2 and their normative inversions. 
Scatter plots a and b depict the result of closest mean classification of 
controls and individuals with smith–Magenis syndrome. the arrows 
indicate the change in closest mean classification position of an indi-
vidual and their normative inversion. In each case, the result of the 
normative inversion is to alter the original face or mid-line profile 
to be more like individuals in the affected group. each scatter pro-
vides quantitative corroboration of the clinical evaluation of the shape 
change resulting from the inversion
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Fig. 6  Closest mean classification of inverted controls against origi-
nal controls and affected subgroups. each scatter shows the clos-
est mean classification of the normative inversion of controls with 
respect to the means of the original control and syndrome subgroup. 
In each case, the inverted controls cluster with the original controls 
and do not show evidence of facial features of the syndrome. a: Wil-
liams–Beuren syndrome b: Wolf–Hirschhorn syndrome c: silver–
russell syndrome d: smith–Magenis syndrome e: rubinstein–taybi 
syndrome
1124 Hum Genet (2014) 133:1117–1125
1 3
employing closest mean classification to determine dis-
criminating differences between 387 controls and their 
inverted forms. the average discrimination rate of 20 %, 
much lower than even chance classification, demonstrates 
that as a group normative inversions of control faces are 
indistinguishable from originals i.e., they fall within typical 
facial growth and development. Finally, to detect any possi-
bility of facial inversion producing features similar to those 
of Williams–Beuren syndrome, we also tested closest mean 
classification of normatively inverted controls in a control-
Williams–Beuren syndrome combined DsM. the result-
ing classification clearly demonstrates that inversion does 
not introduce Williams–Beuren-like facial characteristics 
(Fig. 6a). this was repeated for Wolf–Hirschhorn, silver–
russell, rubinstein–taybi and smith–Magenis syndromes, 
all with similar negative results (Fig. 6b–e).
Conclusion
We have demonstrated the efficacy of normative inversion 
of facial form in the investigation of gene-dosage effects 
at 4p16.3, 7q11.23, 11p15, 16p13.3 and 17p11.2. there is 
a resemblance between normatively inverted faces of indi-
viduals with a duplication or (epi-)mutation and the facial 
characteristics of deletion or mutation cases, and vice 
versa. On chromosome 4p16.3, the genes TACC3, FGFR3, 
and LETM1 have been shown to be dosage sensitive (Cyr 
et al. 2011). two related genes on 7q11.23, GTF2IRD1 and 
GTF2I, have been implicated in the cause of craniofacial 
dysmorphism in Williams–Beuren syndrome and there 
is evidence of dosage-sensitivity (tassabehji et al. 2006). 
BaZ1B has also been implicated in craniofacial develop-
ment in Williams–Beuren syndrome (ashe et al. 2008), 
although its role is still unclear (Yoshimura et al. 2009). 
Dosage sensitivity of CREBBP was established by the 
identification of low-level mosaic individuals with a typi-
cal rubinstein–taybi syndrome phenotype (Gervasini et al. 
2007). Mouse studies of RAI1 have also identified oppo-
site behavioural phenotypes with respect to either deletion 
or duplication (Carmona-Mora and Waltz 2010). Here, we 
have demonstrated that face shape inversion can be used to 
investigate how diametric changes in gene dosage influence 
craniofacial form.
In studying duplication cases, clinicians often remain 
uncertain about their pathogenicity, and it is often difficult 
to determine reliably whether or not the facial dysmor-
phism in a patient is consistent. It might be useful, there-
fore, to compare the inverted face of an individual with a 
duplication of uncertain significance to faces of individu-
als with deletions or mutations in genes of the same region 
in whom the phenotype has been more clearly defined. 
this approach would, for example, be useful for screening 
individuals with uncertain Cnvs recorded in on-line data-
bases such as Decipher (Firth et al. 2009). Conversely, the 
inverted faces of individuals with a deletion or a mutation 
could be a useful visualisation of possible facial features 
associated with duplications of associated genomic regions, 
especially those containing known dosage sensitive genes, 
which should assist recognition.
the inverted facial form we have prescribed is simply 
defined but by the same token is a rather gross transforma-
tion to apply across the entire face. More localised applica-
tion, for example to facial profile or perinasal and perior-
bital regions, will sometimes be more appropriate. larger 
numbers of age, sex and ethnicity matched controls will 
improve the accuracy of matched norms and normative 
inversions. animal studies, such as the recent linkage of 
non-coding regions to facial form (attanasio et al. 2013), 
using normative transformation of facial and cranial struc-
tures will be an appropriate route for determining where, 
to what degree, and at what stage, specific genes produce 
dosage-sensitive effects on facial, cranial and potentially 
brain development (Crespi 2013). Our results have taken an 
initial step in demonstrating the use of normative inversion 
of human faces in the study of gene dosage sensitivity.
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